scPharmaceuticals SCPH Stock
scPharmaceuticals Price Chart
scPharmaceuticals SCPH Financial and Trading Overview
| scPharmaceuticals stock price | 3.54 USD |
| Previous Close | 10.73 USD |
| Open | 10.66 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1000 |
| Day's Range | 10.55 - 10.9 USD |
| 52 Week Range | 3.68 - 12.75 USD |
| Volume | 422.84K USD |
| Avg. Volume | 364.84K USD |
| Market Cap | 384.88M USD |
| Beta (5Y Monthly) | 0.194718 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.92 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 19.2 USD |
SCPH Valuation Measures
| Enterprise Value | 305.19M USD |
| Trailing P/E | N/A |
| Forward P/E | -9.962963 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 186.56108 |
| Price/Book (mrq) | 5.077867 |
| Enterprise Value/Revenue | 147.937 |
| Enterprise Value/EBITDA | -7.547 |
Trading Information
scPharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.194718 |
| 52-Week Change | 150.23% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.75 USD |
| 52 Week Low | 3.68 USD |
| 50-Day Moving Average | 10.51 USD |
| 200-Day Moving Average | 7.51 USD |
SCPH Share Statistics
| Avg. Volume (3 month) | 364.84K USD |
| Avg. Daily Volume (10-Days) | 421.06K USD |
| Shares Outstanding | 35.77M |
| Float | 19.29M |
| Short Ratio | 12.77 |
| % Held by Insiders | 6.51% |
| % Held by Institutions | 69.08% |
| Shares Short | 4.48M |
| Short % of Float | 14.94% |
| Short % of Shares Outstanding | 12.52% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1961.75% |
| Gross Margin | 70.67% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.77% |
| Return on Equity (ttm) | -64.40% |
Income Statement
| Revenue (ttm) | 2.06M USD |
| Revenue Per Share (ttm) | 0.07 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -40437000 USD |
| Net Income Avi to Common (ttm) | -40317000 USD |
| Diluted EPS (ttm) | -1.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 117.36M USD |
| Total Cash Per Share (mrq) | 3.28 USD |
| Total Debt (mrq) | 37.68M USD |
| Total Debt/Equity (mrq) | 49.7 USD |
| Current Ratio (mrq) | 16.376 |
| Book Value Per Share (mrq) | 2.119 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -43702000 USD |
| Levered Free Cash Flow (ttm) | -27801000 USD |
Profile of scPharmaceuticals
| Country | United States |
| State | MA |
| City | Burlington |
| Address | 2400 District Avenue |
| ZIP | 01803 |
| Phone | 617 517 0730 |
| Website | https://www.scpharmaceuticals.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 96 |
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
Q&A For scPharmaceuticals Stock
What is a current SCPH stock price?
scPharmaceuticals SCPH stock price today per share is 3.54 USD.
How to purchase scPharmaceuticals stock?
You can buy SCPH shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for scPharmaceuticals?
The stock symbol or ticker of scPharmaceuticals is SCPH.
Which industry does the scPharmaceuticals company belong to?
The scPharmaceuticals industry is Biotechnology.
How many shares does scPharmaceuticals have in circulation?
The max supply of scPharmaceuticals shares is 52.79M.
What is scPharmaceuticals Price to Earnings Ratio (PE Ratio)?
scPharmaceuticals PE Ratio is now.
What was scPharmaceuticals earnings per share over the trailing 12 months (TTM)?
scPharmaceuticals EPS is -1.92 USD over the trailing 12 months.
Which sector does the scPharmaceuticals company belong to?
The scPharmaceuticals sector is Healthcare.
scPharmaceuticals SCPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 19199.16 USD — |
+2.47
|
8.02B USD — | 18961.69 USD — | 19210.95 USD — | — - | 8.02B USD — |
| NASDAQ Global Select Market Com NQGS | 9395.24 USD — |
+2.49
|
— — | 9276.81 USD — | 9400.1 USD — | — - | — — |
| Nasdaq Health Care IXHC | 946.2 USD — |
+1.52
|
— — | 941.18 USD — | 951.02 USD — | — - | — — |
- {{ link.label }} {{link}}